Gout management as part of secondary cardiovascular prevention: A step forward remains necessary to better understanding.
The paper by Stamp and colleagues (1) contributes to confirming the deleterious role of gout in patients with established cardiovascular (CV) disease. Here this is shown as a shorter time to readmission, mainly for heart failure, but an increased risk of subsequent myocardial infarction, CV-related and all-cause death has also been reported (2). Of interest, these poor outcomes occurred despite appropriate CV management. Gout is a disease with variable levels of inflammation (3), driven by the deposition of monosodium urate crystals.